Please ensure Javascript is enabled for purposes of website accessibility

Why Aphria and Tilray Stocks Are Tanking Today

By Keith Speights - Updated Apr 12, 2021 at 10:29AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Aphria's poor third-quarter performance is weighing on both cannabis stocks.

What happened

Shares of Aphria (APHA) were tanking by 13.2% as of 10:16 a.m. EDT on Monday while shares of Tilray (TLRY) were falling by 11.9%. The declines for both stocks came after Aphria reported disappointing fiscal 2021 third-quarter results before the market opened on Monday.

So what

Aphria badly missed analysts' top- and bottom-line estimates for the third quarter. The Canadian cannabis producer's net revenue slipped 6% year over year to 153.6 million Canadian dollars. Aphria posted an adjusted net loss of CA$47.9 million in Q3, much worse than its adjusted net loss of CA$9.8 million in the prior-year period.

Gloved hand holding cannabis leaf in front of a  Canadian flag

Image source: Getty Images.

The company blamed the worse-than-expected performance primarily on the COVID-19 pandemic. Lockdowns in Canada, particularly Ontario, and in Germany negatively impacted sales.

It makes sense that Aphria's shares would sink on its Q3 update, but what about Tilray? The marijuana stocks have basically moved in lockstep since the announcement of a merger of the two companies. This merger transaction will be an all-stock deal. As a result, any change in Aphria's share price directly impacts Tilray's share price. 

Now what

A special meeting of Aphria shareholders is scheduled for Wednesday of this week to vote on the merger with Tilray. It's likely that the deal will be approved. Assuming there aren't any regulatory roadblocks, the transaction is expected to close in the second quarter of 2021. 

The combined company will rank as the world's biggest cannabis operator. However, merging with Tilray won't eliminate the challenges that Aphria faces. The good news, though, is that Aphria's fortunes could improve as coronavirus worries taper off with the increasing availability of COVID-19 vaccines.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aphria Stock Quote
Aphria
APHA
Tilray Stock Quote
Tilray
TLRY

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
323%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.